Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(13):989-997; doi:10.1093/jnci/dji175
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (31)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Weissfeld, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weissfeld, J. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

ARTICLE

Flexible Sigmoidoscopy in the PLCO Cancer Screening Trial: Results From the Baseline Screening Examination of a Randomized Trial

Joel L. Weissfeld, Robert E. Schoen, Paul F. Pinsky, Robert S. Bresalier, Timothy Church, Susan Yurgalevitch, Joseph H. Austin, Philip C. Prorok, John K. Gohagan
for the PLCO Project Team

Affiliations of authors: University of Pittsburgh Cancer Institute, Pittsburgh, PA (JLW, RES); Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (PFP, PCP, JKG); Henry Ford Hospital, Detroit, MI (RSB); University of Minnesota, Minneapolis, MN (TC); Westat, Rockville, MD (SY); Information Management Services, Inc., Rockville, MD (JHA)

Correspondence to: Joel L. Weissfeld, MD, MPH, UPMC Cancer Pavilion (POB II), 3rd Floor Centre Medical Building, 5150 Centre Avenue, Pittsburgh, PA 15232 (e-mail: jwepid{at}pitt.edu).

Background: The Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial is a randomized clinical trial to test the effectiveness of cancer screening, including the effect of flexible sigmoidoscopy screening on colorectal cancer mortality. Here we report findings from the baseline screening flexible sigmoidoscopy examination. Methods: Analyses included 77 465 men and women aged 55–74 years who were enrolled at 10 screening centers. The trial administered baseline risk factor questionnaires, offered 60-cm flexible sigmoidoscopy examinations, referred patients with screen-detected colorectal polyps or masses to personal physicians, and tracked subjects with polyps or masses to determine results from diagnostic follow-up. Cochran–Mantel–Haenszel statistics and logistic regression were used to test for differences in proportions according to sex and age. Results: A total of 64 658 subjects (83.5%) underwent screening flexible sigmoidoscopy, and at least one polyp or mass was identified in 15 150 subjects (23.4%). Of these, 74.2% received follow-up lower endoscopic procedures. Follow-up lower endoscopy was more frequent in subjects with at least one larger (≥0.5 cm) polyp or mass (86.0% [95% confidence interval {CI} = 84.6% to 87.4%] and 81.0% [95% CI = 79.8% to 82.2%] in women and men, respectively) than in those with a smaller (<0.5 cm) polyp or mass (69.1% [95% CI = 67.5% to 70.6%] and 65.4% [95% CI = 64.1% to 66.7%] in women and men, respectively). The yields per 1000 screened, depending on 5-year age group, were as follows: for colorectal cancer, 1.1–2.5 in women and 2.4–5.6 in men; for advanced adenoma, 18.0–30.4 in women and 36.1–49.1 in men; and for colorectal cancer or any adenoma, 50.6–79.6 in women and 101.9–128.6 in men. Approximately 77% (130/169) of the colorectal adenocarcinoma patients were stage I or II at diagnosis. Conclusions: Acceptance of screening flexible sigmoidoscopy was high. Diagnostic follow-up varied according to polyp size, yet cancer or adenoma detection rates met expectations.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
E. P. Whitlock, J. S. Lin, E. Liles, T. L. Beil, and R. Fu
Screening for Colorectal Cancer: A Targeted, Updated Systematic Review for the U.S. Preventive Services Task Force
Ann Intern Med, October 6, 2008; (2008) 0000605-200811040-00245.
[Abstract] [Full Text]


Home page
CA Cancer J ClinHome page
B. Levin, D. A. Lieberman, B. McFarland, R. A. Smith, D. Brooks, K. S. Andrews, C. Dash, F. M. Giardiello, S. Glick, T. R. Levin, et al.
Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
CA Cancer J Clin, May 1, 2008; 58(3): 130 - 160.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
J. G. Ravenel, P. Costello, and G. A. Silvestri
Screening for Lung Cancer
Am. J. Roentgenol., March 1, 2008; 190(3): 755 - 761.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. E Millen, A. F Subar, B. I Graubard, U. Peters, R. B Hayes, J. L Weissfeld, L. A Yokochi, R. G Ziegler, and for the Prostate, Lung, Colorectal, and Ovarian (P
Fruit and vegetable intake and prevalence of colorectal adenoma in a cancer screening trial
Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1754 - 1764.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
B. Denis, M. Ruetsch, P. Strentz, J. Y. Vogel, F. Guth, J. M. Boyaval, X. Pagnon, J. F. Ebelin, I. Gendre, and P. Perrin
Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test
Gut, November 1, 2007; 56(11): 1579 - 1584.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. I. Berndt, W.-Y. Huang, N. Chatterjee, M. Yeager, R. Welch, S. J. Chanock, J. L. Weissfeld, R. E. Schoen, and R. B. Hayes
Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma
Carcinogenesis, September 1, 2007; 28(9): 1965 - 1970.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
V. A. Kirsh, U. Peters, S. T. Mayne, A. F. Subar, N. Chatterjee, C. C. Johnson, and R. B. Hayes
Prospective Study of Fruit and Vegetable Intake and Risk of Prostate Cancer
J Natl Cancer Inst, August 1, 2007; 99(15): 1200 - 1209.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
G. Loewen, N. Natarajan, D. Tan, E. Nava, D. Klippenstein, M. Mahoney, M. Cummings, and M. Reid
Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessment
Thorax, April 1, 2007; 62(4): 335 - 340.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. L. Mai, J. Sullivan-Halley, G. Ursin, D. O. Stram, D. Deapen, D. Villaluna, P. L. Horn-Ross, C. A. Clarke, P. Reynolds, R. K. Ross, et al.
Physical Activity and Colon Cancer Risk among Women in the California Teachers Study
Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 517 - 525.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H. Brenner, J. Chang-Claude, C. M. Seiler, T. Sturmer, and M. Hoffmeister
Potential for Colorectal Cancer Prevention of Sigmoidoscopy Versus Colonoscopy: Population-Based Case Control Study
Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 494 - 499.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
E. J. Bini, J. Park, and F. Francois
Use of Flexible Sigmoidoscopy to Screen for Colorectal Cancer in HIV-Infected Patients 50 Years of Age and Older.
Arch Intern Med, August 14, 2006; 166(15): 1626 - 1631.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.